Active Biotech AB (publ)
STO: ACTI.ST0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Stockholm Stock Exchange
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Helen Tuvesson
- Employees
- 6
- Headquarters
- Lund, Sweden
- IPO year
- 2003
- Market cap
- SEK 71.7M
- Website
- https://www.activebiotech.com
Loading ACTI…
Loading profile data…Frequently asked questions about ACTI
What does Active Biotech AB (publ) (ACTI.ST) do?
Active Biotech AB (publ), a biotechnology company, develops pharmaceutical products the treatment of oncology and immunology diseases in Sweden. It is developing Tasquinimod, a small molecule immuno-modulator, which is in Phase Ib/IIa clinical trial to treat multiple myeloma; Laquinimod, an immunomodulator that is in phase I clinical trial for t...
Where does ACTI.ST trade?
Active Biotech AB (publ) (ACTI.ST) trades on the Stockholm Stock Exchange.
What sector is ACTI.ST in?
Active Biotech AB (publ) (ACTI.ST) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Active Biotech AB (publ)?
Helen Tuvesson is the chief executive officer of Active Biotech AB (publ) (ACTI.ST).
Where is Active Biotech AB (publ) headquartered?
Active Biotech AB (publ) is headquartered in Sweden.
Does ACTI.ST pay a dividend?
Active Biotech AB (publ) (ACTI.ST) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did ACTI.ST go public?
Active Biotech AB (publ) (ACTI.ST) completed its initial public offering in 2003.